论文信息 - Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer. - 字舞流文

Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer.

M. Untch | C. Thomssen | G. Konecny | H. Meerpohl | A. Dubois | C. Lindner | H. Luck | B. Lisboa | K. Diergarten | D. Hecker | H. Kuhnle | F. Janicke